Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9643139, 11 pages
https://doi.org/10.1155/2017/9643139
Research Article

The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens

1Department of Toxicology, Faculty of Pharmacy, Wrocław Medical University, Wrocław, Poland
2Department of Urology and Urological Oncology, Wrocław University Hospital, Wrocław, Poland

Correspondence should be addressed to Ewa Sawicka; lp.corw.demu@akciwas.awe

Received 24 February 2017; Revised 14 June 2017; Accepted 3 July 2017; Published 8 August 2017

Academic Editor: Gian L. Mariottini

Copyright © 2017 Beata Szymańska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. T. Chung, “The etiology of bladder cancer and its prevention,” Journal of Cancer Science Therapy, vol. 5, no. 10, pp. 346–361, 2013. View at Google Scholar
  2. K. J. Kiriluk, S. M. Prasad, A. R. Patel, G. D. Steinberg, and N. D. Smith, “Bladder cancer risk from occupational and environmental exposures,” Urologic Oncology: Seminars and Original Investigations, vol. 30, no. 2, pp. 199–211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ferrís, J. Garcia, O. Berbel, and J. A. Ortega, “Constitutional and occupational risk factors associated with bladder cancer,” Actas Urologicas Espanolas, vol. 37, no. 8, pp. 513–522, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Dlugosz, J. Gąsior, and A. Guzik, “The influence of environmental risk factors on the development of bladder cancer,” Nowotwory, vol. 65, no. 1, pp. 35–41, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. D. W. Hein, “Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis,” Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, vol. 506, no. 507, pp. 65–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Volanis, T. Kadiyska, A. Galanis, D. Delakas, S. Logotheti, and V. Zoumpourlis, “Environmental factors and genetic susceptibility promote urinary bladder cancer,” Toxicology Letters, vol. 193, no. 2, pp. 131–137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. F. Shariat, J. P. Sfakianos, M. J. Droller, P. I. Karakiewicz, S. Meryn, and B. H. Bochner, “The effect of age and gender on bladder cancer: a critical review of the literature,” BJU International, vol. 105, no. 3, pp. 300–308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Gunlusoy, Y. Ceylan, T. Degirmenci et al., “The potential effect of age on the natural behavior of bladder cancer: does urothelial cell carcinoma progress differently in various age groups?” Kaohsiung Journal of Medical Sciences, vol. 32, no. 5, pp. 261–266, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Davido and R. H. Getzenberg, “Nuclear matrix proteins as cancer markers.,” Journal of cellular biochemistry. Supplement, vol. 35, pp. 136–141, 2000. View at Google Scholar · View at Scopus
  10. W. Spenser and J. R. Davie, “Signal transduction pathways and chromatin structure in cancer,” Journal of Cellular Biochemistry, vol. 9, no. 35, pp. 27–35, 2000. View at Google Scholar
  11. H. Jamshidian, K. Kor, and M. Djalali, “Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.,” Urology journal, vol. 5, no. 4, pp. 243–247, 2008. View at Google Scholar · View at Scopus
  12. S. Huber, C. Schwentner, D. Taeger et al., “Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study,” BJU International, vol. 110, no. 5, pp. 699–708, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Rybotycka and A. Dlugosz, “Laboratory tests in bladder cancer. The role of the NMP22 protein,” Polski Merkuiusz Lekarski, vol. 38, no. 1, pp. 309–314, 2015. View at Google Scholar
  14. B. R. Konety, T.-S. T. Nguyen, R. Dhir et al., “Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4,” Clinical Cancer Research, vol. 6, no. 7, pp. 2618–2625, 2000. View at Google Scholar · View at Scopus
  15. Q. Zhao, W.-H. Shen, Z.-W. Chen, Z.-S. Zhou, and H.-X. Ji, “High expression level of BLCA-4 correlates with poor prognosis in human bladder cancer,” International Journal of Clinical and Experimental Pathology, vol. 5, no. 5, pp. 422–427, 2012. View at Google Scholar · View at Scopus
  16. M. Santoni, F. Catanzariti, D. Minardi et al., “Pathogenic and diagnostic potential of BLCA-1 and BLCA-4 nuclear proteins in urothelial cell carcinoma of human bladder,” Advances in Urology, Article ID 397412, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. J. Sherratt and J. D. Hayes, “Enzyme Systems that Metabolise Drugs and Other Xenobiotics. Glutathione S-transferases,” in UK, chapter 9, pp. 319–352, John Wiley&Sons Ltd, Chichester, UK, 2001. View at Google Scholar
  18. K. D. Tew, Y. Manevich, C. Grek, Y. Xiong, J. Uys, and D. M. Townsend, “The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 299–313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Antonowa, D. Toncheva, and E. E. Grigorov, “Bladder cancer risk from the perspective of genetic polymorphisms in the carcinogen metabolizing enzymes,” Journal of Balkan Union of Oncology, vol. 20, no. 6, pp. 1397–1406, 2015. View at Google Scholar
  20. B. V. Jardim, M. G. Moschetta, G. B. Gelaleti et al., “Glutathione transferase pi (GSTpi) expression in breast cancer: an immunohistochemical and molecular study,” Acta Histochemica, vol. 114, no. 5, pp. 510–517, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Szymanska, K. J. Pawlik, E. Sawicka et al., “Evaluation of NMP22 in bladder cancer patients sensitive to environmental toxins,” Advances in Clinical and Experimental Medicine, http://www.advances.umed.wroc.pl/ahead-of-print/2018/27/1/63156.pdf. View at Publisher · View at Google Scholar
  22. M. Pljesa-Ercegovac, A. Savic-Radojevic, D. Dragicevic et al., “Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways,” Urologic Oncology: Seminars and Original Investigations, vol. 29, no. 1, pp. 70–77, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Garcia-Closas, N. Malats, D. Silverman et al., “NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the spanish bladder cancer study and meta-analyses,” Lancet, vol. 366, no. 9486, pp. 649–659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. D. W. Hein, “N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk,” Oncogene, vol. 25, no. 11, pp. 1649–1658, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. L. L. Wu, C.-C. Chiou, P.-Y. Chang, and J. T. Wu, “Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics,” Clinica Chimica Acta, vol. 339, no. 1-2, pp. 1–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-J. Chung, C.-J. Huang, Y.-S. Pu et al., “Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area,” Toxicology and Applied Pharmacology, vol. 226, no. 1, pp. 14–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. H.-I. Chen, S.-H. Liou, S.-F. Ho et al., “Oxidative DNA damage estimated by plasma 8-hydroxydeoxyguanosine (8-OHdG): influence of 4, 4′-methylenebis (2-chloroaniline) exposure and smoking,” Journal of Occupational Health, vol. 49, no. 5, pp. 389–398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. B. P. Mishra, Z. G. Badade, B. K. Anand, J. L. Lingidi, and S. Jaiswal, “8-Hydroxydeoxyguanosine (8-OHdG) levels in urinary samples of pesticide sprayers on exposure to organophosphorus pesticides,” International Journal of Clinical Trials, vol. 2, no. 3, p. 59, 2015. View at Publisher · View at Google Scholar
  29. L. H. Sobin, M. K. Gospodarowicz, and C. H. Wittekind, ICC International Union Against Cancer. TNM Classification of Malignant Tumors, Wiley-Blackwell Ltd., 2009.
  30. D. A. Bell, J. A. Taylor, M. A. Butler et al., “Short communication: genotype/phenotype discordance for human arylamine n-acetyltransferase (nat2) reveals a new slow-acetylator allele common in african-americans,” Carcinogenesis, vol. 14, no. 8, pp. 1689–1692, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Nakago, R. M. Hadfield, K. T. Zondervan et al., “Association between endometriosis and N-acetyl1 transferase 2 polymorphisms in a UK population,” Molecular Human Reproduction, vol. 7, no. 11, pp. 1079–1083, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Zabost, S. Brzezińska, M. Kozińska et al., “Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in polish tuberculosis patients,” BioMed Research International, vol. 2013, Article ID 853602, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Hanczyk, “StatSoft Poland. ROC curves, quality assessment classifier and the search for the optimum point 2010,” 2010, http://www.statsoft.pl/Portals/0/Downloads/ROC_curves_or_quality_assessment.pdf.
  34. A. Kumar, R. Kumar, and N. P. Gupta, “Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer,” Japanese Journal of Clinical Oncology, vol. 36, no. 3, pp. 172–175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Wadhwa, S. K. Jatawa, and A. Tiwari, “Non-invasive urine based tests for the detection of bladder cancer,” Journal of Clinical Pathology, vol. 65, no. 11, pp. 970–975, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. L. Smith and T. J. Guzzo, “Urinary markers for bladder cancer,” F1000Prime Reports, vol. 5, article no. 21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Y. Joung, S. Park, H. Yoon et al., “Overestimation of nuclear matrix protein 22 in concentrated urine,” Urology, vol. 82, no. 5, pp. 1059–1064, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. F. Shariat, C. Zippe, G. Lübecke et al., “Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder,” Journal of Urology, vol. 173, no. 5, pp. 1518–1525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Feng, P. H. Wang, M. Guan, and Z. Wu, “Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness,” Folia Biologica, vol. 57, no. 6, pp. 242–247, 2011. View at Google Scholar
  40. X. Li, J. Pi, B. Li, Y. Xu, Y. Jin, and G. Sun, “Urinary arsenic speciation and its correlation with 8-OHdG in Chinese residents exposed to arsenic through coal burning,” Bulletin of Environmental Contamination and Toxicology, vol. 81, no. 4, pp. 406–411, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. T.-S. Lin, C.-C. Wu, J.-D. Wu, and C.-H. Wei, “Oxidative DNA damage estimated by urinary 8-hydroxy-2′-deoxyguanosine and arsenic in glass production workers,” Toxicology and Industrial Health, vol. 28, no. 6, pp. 513–521, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Chen, L. Qu, B. Li et al., “Increased oxidative DNA damage, as assessed by urinary 8-hydroxy-2′-deoxyguanosine concentrations, and serum redox status in persons exposed to mercury,” Clinical Chemistry, vol. 51, no. 4, pp. 759–767, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Soini, K.-M. Haapasaari, M. H. Vaarala, T. Turpeenniemi-Hujanen, V. Kärjä, and P. Karihtala, “8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma,” International Journal of Clinical and Experimental Pathology, vol. 4, no. 3, pp. 267–275, 2011. View at Google Scholar · View at Scopus
  44. T. Wada, N. Tanji, A. Ozawa et al., “Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine content in Japanese patients with urinary bladder and renal cancers,” Anticancer Research, vol. 26, no. 5 A, pp. 3403–3408, 2006. View at Google Scholar · View at Scopus
  45. T. Akçay, I. Saygili, G. Andican, and V. Yalçin, “Increased formation of 8-hydroxy-2′-deoxyguanosine in peripheral blood leukocytes in bladder cancer,” Urologia Internationalis, vol. 71, no. 3, pp. 271–274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Dincer, T. Akçay, A. R. Kural et al., “Evaluation of 8-hydroxy-2'-deoxyguanosine concentration and antioxidant enzyme activities in bladder cancer patients,” Turkiye Klinikleri Journal of Medical Sciences, vol. 31, no. 3, pp. 553–558, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. C.-C. Chiou, P.-Y. Chang, E.-C. Chan, T.-L. Wu, K.-C. Tsao, and J. T. Wu, “Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: Development of an ELISA and measurement in both bladder and prostate cancers,” Clinica Chimica Acta, vol. 334, no. 1-2, pp. 87–94, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. B. R. Konety, T.-S. T. Nguyen, G. Brenes et al., “Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer,” Journal of Urology, vol. 164, no. 3 I, pp. 634–639, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. M. J. Jiang, G. Wu, and J. Q. Hou, “Expression and clinical significance of bladder cancer specific nuclear matrix protein 4 in urine of patients with bladder cancer,” Chinese Journal of Experimental Surgery, vol. 30, no. 8, pp. 1754-1755, 2013. View at Google Scholar
  50. Y. H. Huang, N. Zhou, X. Xu, and Z. Y. Zhang, “The significance of combined detection of specific nuclear matrix protein-4 and bladder cancer antigen in bladder cancer at an early stage,” The Journal of Practical Medicine, vol. 30, no. 22, pp. 3608–3640, 2014. View at Google Scholar
  51. Z. Yinan and W. Guomin, “Allogeneic stem cells seeded tissue engineered bladder: A possible alternative for bladder reconstruction and treatment to bladder cancer,” Medical Hypotheses, vol. 70, no. 2, pp. 294–297, 2008. View at Publisher · View at Google Scholar
  52. J. R. Yang, W. Liu, B. Liu, and T. J. Pan, “Clinical significance of expression of BLCA-4 in urine of bladder cancer patients,” The Practical Journal of Cancer, vol. 30, pp. 168–170, 2015. View at Google Scholar
  53. M. A. Knowles and C. D. Hurst, “Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity,” Nature Reviews Cancer, vol. 15, no. 1, pp. 25–41, 2014. View at Publisher · View at Google Scholar